The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This reflects a decrease in IOLs of 1% constant currency, due to competitive pressures in the U.S. This decline was partially ...

Please provide your email address to receive an email when new articles are posted on . PanOptix Pro maintains the visual outcomes of the original PanOptix design while reducing visual side effects.

Alcon has announced the launch of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in India. PanOptix Pro leverages proprietary ENLIGHTEN® NXT Optical technology which delivers the ...

CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity VCS] is delivering on ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in ...

SEOUL, SOUTH KOREA, May 29, 2026 /EINPresswire.com/ — Dr. Chung Eui Sang, Chief Director of SNU Eye Clinic in Korea, recently served as moderator at the “Clareon ...

Greetings, and welcome to the Alcon Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Dan ...

Stonesifer stated, "We expect top line growth of between 5% and 7%." He added, "We expect core diluted EPS to grow between 9% and 12%" for 2026. The outlook assumes aggregate eye care markets grow 3% ...

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...

TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...